BIIB129
BIIB129 is a brain-penetrant, covalent BTK inhibitor used for research into B-cell driven pathologies. It is employed in both in vitro and in vivo studies to investigate mechanisms of B-cell proliferation and related autoimmune or oncological diseases.
Product Specifications
CAS Number
2770960-52-4
Product Name Alternative
BIIB 129
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.56% (May vary between batches)
Solubility
DMSO:80 mg/mL (218.33 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (9.01 mM)
Smiles
O (C=1C=2N (C=C (N1) C3=CN (C) N=C3) N=CC2) [C@@]4 (C) C[C@@H] (N (C (C=C) =O) C) C4
Molecular Formula
C19H22N6O2
Molecular Weight
366.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6485604 1.0 µg DNA
Tubgcp5 sgRNA CRISPR Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details 
SL1638Hu-01 48 Tests
Human Squamous Cell Carcinoma Antigen (SCCAg) ELISA Kit
Sign In for Pricing
View Details SL1638Hu-02 96 Tests
Human Squamous Cell Carcinoma Antigen (SCCAg) ELISA Kit
Sign In for Pricing
View Details